La contratación pública de las sociedades de economía mixta

The Mixed Economy Companies have had to adapt their procurement to the public contracting rules set on the Public Sector Contracts Law. The transition from private law to the public sector has not been easy, largely due to the legislative de ficiencies that a norm written for the Public Administrations provokes when applied to the Awarding Powers but not Public Administration (PANAPS for their Spanish acronym). The complexity of this public procurement form does not end with the Public Sector Contracts Law, but reaches also to the legal application of other rules originally destined to the Administrations. The 8th November 9/2017 Law devotes a title to this contracting figure, but even before its entry into force presents important controversies regarding legal security.Las Sociedades de Economía Mixta han tenido que adaptar su contratación al régimen propio de la contratación pública de la Ley de Contratos del Sector Público. La transición del derecho privado al derecho público no ha sido fácil, en gran medida por las deficiencias legislativas que una norma redactada para las Administraciones Públicas provoca cuando se aplica a los Poderes Adjudicadores pero no Administración Pública (PANAPS). La complejidad en la contratación de esta figura no se agota con la Ley de Contratos del Sector Público sino que alcanza la aplicación de otras normas originariamente destinadas para las Administraciones. La Ley 9/2017, de 8 de noviembre, destina un título a la contratación de esta figura pero incluso antes de su entrada en vigor presenta importantes controversias contrarias a la seguridad jurídica.Las Sociedades de Economía Mixta han tenido que adaptar su contratación al régimen propio de la contratación pública de la Ley de Contratos del Sector Público. La transición del derecho privado al derecho público no ha sido fácil, en gran medida por las deficiencias legislativas que una norma redactada para las Administraciones Públicas provoca cuando se aplica a los Poderes Adjudicadores pero no Administración Pública (PANAPS). La complejidad en la contratación de esta figura no se agota con la Ley de Contratos del Sector Público sino que alcanza la aplicación de otras normas originariamente destinadas para las Administraciones. La Ley 9/2017, de 8 de noviembre, destina un título a la contratación de esta figura pero incluso antes de su entrada en vigor presenta importantes controversias contrarias a la seguridad jurídica.The Mixed Economy Companies have had to adapt their procurement to the public contracting rules set on the Public Sector Contracts Law. The transition from private law to the public sector has not been easy, largely due to the legislative de ficiencies that a norm written for the Public Administrations provokes when applied to the Awarding Powers but not Public Administration (PANAPS for their Spanish acronym). The complexity of this public procurement form does not end with the Public Sector Contracts Law, but reaches also to the legal application of other rules originally destined to the Administrations. The 8th November 9/2017 Law devotes a title to this contracting figure, but even before its entry into force presents important controversies regarding legal security.

Crossing the Midline Roles and Regulation of Robo Receptors

AbstractIn the Drosophila CNS, the midline repellent Slit acts at short range through its receptor Robo to control midline crossing. Longitudinal axons express high levels of Robo and avoid the midline; commissural axons that cross the midline express only low levels of Robo. Robo levels are in turn regulated by Comm. Here, we show that the Slit receptors Robo2 and Robo3 ensure the fidelity of this crossing decision: rare crossing errors occur in both robo2 and robo3 single mutants. In addition, low levels of either Robo or Robo2 are required to drive commissural axons through the midline: only in robo,robo2 double mutants do axons linger at the midline as they do in slit mutants. Robo2 and Robo3 levels are also tightly regulated, most likely by a mechanism similar to but distinct from the regulation of Robo by Comm

A is for Anthropocene:An A–Z of Design Ecology

This paper lists in A to Z format the changing ecology of design in the Anthropocene. From twenty-six points of view the paper contrasts design’s search for a coherent ecology – how it looks like it looks – with its search for a familiar ecology – how it is understood today. Taking each letter of the alphabet to create individual reviews of the vicissitudes of design, the paper critiques how design has historically explained to itself, and anyone who has been listening, what it has been doing, and contrasts that with what needs to be done

Enfermedad de Urbach-Wiethe: presentación de un caso con afectación bucal tratado con láser de CO2

Se presenta un caso de enfermedad de Urbach-Wiethe o lipoidoproteinosis con extensas lesiones orales que dificultaban la masticación. Se efectuó un remodelado gingival con fotobisturí de láser C02 en dos tiempos, con lo que se obtuvo un resultado sumamente satisfactorio. Se describen las principales características clínicas de esta rara enfermedad y se analiza la utilidad del láser C02 en la cirugía bucal

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

Epidemiology; HIV/HCV coinfection; SpainEpidemiologia; Coinfecció pel VIH/VHC; EspanyaEpidemiologia; Coinfección por el VIH/VHC; EspañaObjectives We assessed the prevalence of anti-hepatitis C virus (HCV) antibodies and active HCV infection (HCV-RNA-positive) in people living with HIV (PLWH) in Spain in 2019 and compared the results with those of four similar studies performed during 2015–2018. Methods The study was performed in 41 centres. Sample size was estimated for an accuracy of 1%. Patients were selected by random sampling with proportional allocation. Results The reference population comprised 41 973 PLWH, and the sample size was 1325. HCV serostatus was known in 1316 PLWH (99.3%), of whom 376 (28.6%) were HCV antibody (Ab)-positive (78.7% were prior injection drug users); 29 were HCV-RNA-positive (2.2%). Of the 29 HCV-RNA-positive PLWH, infection was chronic in 24, it was acute/recent in one, and it was of unknown duration in four. Cirrhosis was present in 71 (5.4%) PLWH overall, three (10.3%) HCV-RNA-positive patients and 68 (23.4%) of those who cleared HCV after anti-HCV therapy (p = 0.04). The prevalence of anti-HCV antibodies decreased steadily from 37.7% in 2015 to 28.6% in 2019 (p < 0.001); the prevalence of active HCV infection decreased from 22.1% in 2015 to 2.2% in 2019 (p < 0.001). Uptake of anti-HCV treatment increased from 53.9% in 2015 to 95.0% in 2019 (p < 0.001). Conclusions In Spain, the prevalence of active HCV infection among PLWH at the end of 2019 was 2.2%, i.e. 90.0% lower than in 2015. Increased exposure to DAAs was probably the main reason for this sharp reduction. Despite the high coverage of treatment with direct-acting antiviral agents, HCV-related cirrhosis remains significant in this population.This work was supported in part by the Spanish AIDS Research Network (RD16/0025/0017, RD16/0025/0018), which is included in the Spanish I+D+I Plan and is co-funded by the ISCIII-Subdirección General de Evaluación and European Funding for Regional Development (FEDER). The sponsors had no role in the study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the article for publication

A spatial and temporal analysis of risk factors associated with sporadic Shiga toxin-producing Escherichia coli O157 infection in England between 2009 and 2015

Infection with STEC O157 is relatively rare but has potentially serious sequelae, particularly for children. Large outbreaks have prompted considerable efforts designed to reduce transmission primarily from food and direct animal contact. Despite these interventions, numbers of infections have remained constant for many years and the mechanisms leading to many sporadic infections remain unclear. Here, we show that two-thirds of all cases reported in England between 2009 and 2015 were sporadic. Crude rates of infection differed geographically and were highest in rural areas during the summer months. Living in rural areas with high densities of cattle, sheep or pigs and those served by private water supplies were associated with increased risk. Living in an area of lower deprivation contributed to increased risk but this appeared to be associated with reported travel abroad. Fresh water coverage and residential proximity to the coast were not risk factors. To reduce the overall burden of infection in England, interventions designed to reduce the number of sporadic infections with STEC should focus on the residents of rural areas with high densities of livestock and the effective management of non-municipal water supplies. The role of sheep as a reservoir and potential source of infection in humans should not be overlooked

Application of kernel smoothing to estimate the spatio-temporal variation in risk of STEC O157 in England

Identifying geographical areas with significantly higher or lower rates of infectious diseases can provide important aetiological clues to inform the development of public health policy and interventions designed to reduce morbidity. We applied kernel smoothing to estimate the spatial and spatio-temporal variation in risk of STEC O157 infection in England between 2009 and 2015, and to explore differences between the residential locations of cases reporting travel and those not reporting travel. We provide evidence that the distribution of STEC O157 infection in England is non-uniform with respect to the distribution of the at-risk population; that the spatial distribution of the three main genetic lineages infecting humans (I, II and I/II) differs significantly and that the spatio-temporal risk is highly dynamic. Our results also indicate that cases of STEC O157 reporting travel within or outside the UK are more likely to live in the south/south-east of the country, meaning that their residential location may not reflect the location of exposure that led to their infection. We suggest that the observed variation in risk reflects exposure to sources of STEC O157 that are geographically prescribed. These differences may be related to a combination of changes in the strains circulating in the ruminant reservoir, animal movements (livestock, birds or wildlife) or the behavior of individuals prior to infection. Further work to identify the importance of behaviours and exposures reported by cases relative to residential location is needed

CLIPPERS syndrome with atypical distribution of lesions in magnetic resonance imaging of the brain

Introducción. El síndrome CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) es un proceso inflamatorio del sistema nervioso central cuyo rasgo distintivo son las lesiones puntiformes en el troncoencéfalo captantes en los estudios de resonancia magnética. Clínicamente, cursa con disartria, ataxia y diplopía, y suele responder a corticoides. Anatomopatológicamente, aparecen infiltrados de linfocitos T en los espacios perivasculares troncoencefálicos. Caso clínico. Mujer de 40 años con cuadro de instauración subaguda de diplopía binocular, ataxia y disartria. En la resonancia magnética cerebral presentó lesiones puntiformes hipertintensas en secuencia T2 en el tronco, cerebelo, diencéfalo y áreas córtico-subcorticales bihemisféricas, que realzaron con contraste. Se realizó un estudio etiológico para descartar un origen infeccioso, neoplásico o inflamatorio subyacente, que resultó negativo. La paciente recibió tratamiento en dos ocasiones con metilprednisolona, con descenso progresivo de la dosis, con buena respuesta. Conclusiones. La diplopía y la ataxia, como en nuestro caso, están presentes prácticamente siempre. Los hallazgos en la RM consisten en lesiones captantes puntiformes localizadas en la protuberancia con extensión hacia el cerebelo, ganglios basales y cuerpo calloso, con gradiente de captación menor conforme se alejan rostralmente hacia la corteza, y caudalmente hacia la médula. En el caso de nuestra paciente, este gradiente no se respeta, encontrándose una densidad similar de las lesiones a nivel supratentorial. El diagnóstico diferencial es amplio y justifica un estudio diagnóstico extenso, y en casos seleccionados la biopsia cerebral. El curso de la enfermedad es remitente-recurrente, y el pronóstico mejora cuanto más precoz y prolongado es el tiempo de corticoterapiaIntroduction. CLIPPERS syndrome (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) is an inflammatory process of the central nervous system whose distinguishing features are the enhancing punctiform lesions in the brainstem that appear in the magnetic resonance images. Clinically, it is accompanied by dysarthria, ataxia and diplopia, and usually responds to treatment with corticoids. Pathologically, T lymphocytes appear infiltrated in the perivascular spaces of the brainstem. Case report. We report the case of a 40-year-old woman with an initial subacute clinical picture of binocular diplopia, ataxia and dysarthria. The magnetic resonance brain scan revealed T2 hyperintense punctiform lesions in the stem, cerebellum, diencephalons and cortico-subcortical areas of both hemispheres, which were enhanced with contrast. An aetiological study was performed to rule out any underlying infectious, neoplastic or inflammatory origin, the results being negative. The patient was treated on two occasions with methylprednisolone, with a gradual lowering of the dosage, the response being favourable. Conclusions. Diplopia and ataxia, as in our case, are practically always present. The MR findings consist of punctiform enhancing lesions located in the pons extending towards the cerebellum, basal ganglia and corpus callosum, the enhancement gradient becoming lower as the distance increases rostrally away from the cortex, and caudally towards the spinal cord. In the case of our patient, this gradient is not respected, and the density found was similar to that of lesions at the supratentorial level. The differential diagnosis is wide-ranging and justifies an extensive diagnostic study with, in certain cases, a biopsy study of brain tissue. The disease courses in a relapsing-remitting pattern and the earlier steroid therapy is established and the more prolonged it is, the better the prognosis will b

Vagus nerve stimulation in patients with migraine

ntroducción. La estimulación del nervio vago (ENV) está aprobada para el tratamiento de la epilepsia refractaria cuando no es posible cirugía resectiva, con una eficacia bien establecida. Series publicadas sugieren un efecto beneficioso de la ENV en la migraña. Objetivos. Determinar el grado de mejoría de la cefalea en pacientes migrañosos a los que se les había implantado una ENV para tratamiento de la epilepsia refractaria y evaluar qué variables se asocian a mayor posibilidad de éxito con esta medida. Pacientes y métodos. Estudio observacional y retrospectivo desde el 1 de enero de 1999 hasta el 31 de diciembre de 2010. Se contactó telefónicamente con los pacientes con ENV para epilepsia refractaria, seleccionando a aquéllos que cumplían los criterios de la Sociedad Internacional de Cefaleas para la migraña. Se recogieron edad, género, año de implantación, edad de inicio de la epilepsia y la migraña, mejoría de crisis y de migraña, presencia de aura migrañosa y coexistencia de síndrome ansiosodepresivo. Se contactó con 94 pacientes con ENV y se seleccionó a 13 pacientes migrañosos. Resultados. Tras la implantación de la ENV, se observó una disminución de al menos el 50% de los episodios de migraña en nueve pacientes (69%) (p = 0,004), así como una disminución del número de episodios de migraña en aquellos pacientes que también habían reducido sus crisis epilépticas (p = 0,012). No se observaron asociaciones estadísticamente significativas en cuanto al sexo, edad, tiempo de evolución, existencia de aura migrañosa o coexistencia de síndrome ansiosodepresivo. Conclusiones. La ENV podría resultar beneficiosa en pacientes con migraña, especialmente en casos de difícil control. Debido al tipo estudio, hay que tomar estas conclusiones con precaución. Serán necesarios estudios clínicos prospectivos antes de llevarse a la práctica clínica habitualIntroduction. Vagus nerve stimulation (VNS) has been approved for the treatment of refractory epilepsy when resective surgery is not possible, and has proved to be highly effective. Series published in the literature suggest a beneficial effect of VNS in the treatment of migraine. Aims. To determine the degree to which headaches improve in patients with migraine after the placement of VNS to treat refractory epilepsy, and to evaluate what variables are associated with an increased chance of success with this measure. Patients and methods. An observation-based retrospective study was conducted from 1st January 1999 until 31st December 2010. Patients with VNS for refractory epilepsy were contacted by telephone, after selecting those who fulfilled International Headache Society criteria for migraine. Data collected included age, gender, year of placement, age at onset of epilepsy and migraine, improvement of seizures and migraine, presence of migraine with aura and coexistence of anxious-depressive syndrome. Ninety-four patients with VNS were contacted and 13 patients with migraine were selected. Results. Following placement of the VNS, the number of episodes of migraine was seen to decrease by at least 50% in nine patients (69%) (p = 0.004) and there was a drop in the number of episodes of migraine in those patients who had also reduced their epileptic seizures (p = 0.012). No statistically significant associations were observed as regards sex, age, length of disease history, existence of migraine with aura or coexistence of anxious-depressive syndrome. Conclusions. VNS could have beneficial effects for patients with migraine, especially in cases that are difficult to control. Due to the type of study, these conclusions must be taken with caution. Prospective clinical studies are needed before introducing the technique into daily clinical practic